Hindustan Laboratories files preliminary papers with SEBI for IPO

06 Jan 2026 Evaluate

Hindustan Laboratories has filed preliminary papers with capital markets regulator Securities and Exchange Board of India (SEBI) to raise funds through an initial public offering (IPO). The company's maiden public offering comprises a fresh issue of 50 lakh shares along with an Offer for sale (OFS) of 91 lakh shares by the promoter. 

The company proposes to utilize IPO proceeds for funding the working capital requirements and general corporate purposes. Choice Capital Advisors has been appointed as the book-running lead manager to the issue. 

Hindustan Laboratories is an Indian pharmaceutical company primarily engaged in the large-scale manufacturing and supply of generic medicines to government institutions under a business-to-government (B2G) framework.


Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×